3-o-methyl-alpha-methyldopamine has been researched along with alpha-methylepinine in 1 studies
| Studies (3-o-methyl-alpha-methyldopamine) | Trials (3-o-methyl-alpha-methyldopamine) | Recent Studies (post-2010) (3-o-methyl-alpha-methyldopamine) | Studies (alpha-methylepinine) | Trials (alpha-methylepinine) | Recent Studies (post-2010) (alpha-methylepinine) |
|---|---|---|---|---|---|
| 15 | 0 | 1 | 28 | 3 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, MH; Blough, BE; Goldberg, SR; Schindler, CW; Tella, SR; Thorndike, EB | 1 |
1 other study(ies) available for 3-o-methyl-alpha-methyldopamine and alpha-methylepinine
| Article | Year |
|---|---|
Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiovascular System; Consciousness; Deoxyepinephrine; Dopamine; Dose-Response Relationship, Drug; Hallucinogens; Heart Rate; Male; Metabolic Detoxication, Phase I; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Telemetry; Time Factors | 2014 |